Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1284395

registered interest
date	05/02/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	TRIPS Agreement
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has undertaken an impact assessment on public health implications for the UK in the event that the proposed World Trade Organisation TRIPS Waiver is not approved.
tabling member constituency	Norwich South
tabling member printed	Clive Lewis
uin	149799
answer	answer is ministerial correction date of answer 15/02/2021 answer text <p>The Government has made no such assessment and does not consider waiving intellectual property rights to be an appropriate course of action to boost the manufacturing of safe, effective and quality vaccines. The existing intellectual property framework has mobilised research and development to deliver a host of new medicines and technologies, to detect, treat and defend against COVID-19.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 15/02/2021 17:26:12 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4500 label Biography information for Clive Lewis

1284396

registered interest
date	05/02/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Intellectual Property
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, whether his Department has undertaken an impact assessment on potential economic costs for the UK in the event that the proposed World Trade Organisation TRIPS Waiver is not approved.
tabling member constituency	Norwich South
tabling member printed	Clive Lewis
uin	149800
answer	answer is ministerial correction date of answer 15/02/2021 answer text <p>The UK Government does not consider waiving IP rights to be an appropriate course of action to boost the manufacturing of safe, effective and quality vaccines.</p><p> </p><p>The existing intellectual property framework has mobilised research and development to deliver a host of new medicines and technologies, to detect, treat and defend against COVID-19. The incentives and access mechanisms provided by the IP framework have been integral to this success, without which we would not have seen the impressive surge of R&amp;D and the unprecedented scaling up of production.</p> answering member constituency Derby North answering member printed Amanda Solloway question first answered 15/02/2021 17:51:37 answering member 4372 label Biography information for Amanda Solloway
tabling member	4500 label Biography information for Clive Lewis

1284397

registered interest
date	05/02/2021
answering body	Foreign, Commonwealth and Development Office
answering dept id	208
answering dept short name	Foreign, Commonwealth and Development Office
answering dept sort name	Foreign, Commonwealth and Development Office
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what assessment the Government has made of the effect on global equality of access to the covid-19 vaccines in the event that the proposed WTO TRIPS Waiver is not adopted.
tabling member constituency	Norwich South
tabling member printed	Clive Lewis
uin	149801
answer	answer is ministerial correction date of answer 15/02/2021 answer text <p>The UK is committed to rapid equitable access to safe and effective vaccines, and is playing a leading role in financing the global effort, and identifying solutions that ensure affordable access for all.</p><p>The UK Government does not consider waiving intellectual property (IP) rights to be an appropriate course of action in boosting the manufacturing of safe, effective, and quality vaccines. The existing intellectual property framework has mobilised research and development to deliver a host of new medicines and technologies to detect, treat, and defend against COVID-19. The incentives and access mechanisms provided by the IP framework have been integral to this success, without which we would not have seen the impressive surge of research and development, and the unprecedented scaling up of production.</p> answering member constituency Aldridge-Brownhills answering member printed Wendy Morton question first answered 15/02/2021 09:33:49 answering member 4358 label Biography information for Wendy Morton
tabling member	4500 label Biography information for Clive Lewis

1284399

registered interest
date	05/02/2021
answering body	Department for International Trade
answering dept id	202
answering dept short name	International Trade
answering dept sort name	International Trade
hansard heading	TRIPS Agreement
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for International Trade, if she will publish statements made by the Government related to the proposed TRIPS Waiver at the World Trade Organisation TRIPS Council Meeting on 4 February 2021.
tabling member constituency	Norwich South
tabling member printed	Clive Lewis
uin	149802
answer	answer is ministerial correction date of answer 15/02/2021 answer text <p>The UK has engaged regularly in debates at the World Trade Organisation (WTO) TRIPS Council and other international institutions to promote affordable and equitable global access to COVID-19 vaccines, including in developing countries. We respect the informal format of WTO discussions and do not publish proceedings from those meetings. However, at the informal TRIPS Council on 4 February 2021, the UK sought to further understand the parameters of the proposed waiver and asked for clarifications from the waiver’s proponents. This remains consistent with the Government’s approach to encourage evidence-based discussions between WTO Members to find solutions to present issues within the multilateral intellectual property framework.</p> answering member constituency Chelsea and Fulham answering member printed Greg Hands question first answered 15/02/2021 11:53:53 answering member 1526 label Biography information for Greg Hands
tabling member	4500 label Biography information for Clive Lewis

1284400

registered interest
date	05/02/2021
answering body	Foreign, Commonwealth and Development Office
answering dept id	208
answering dept short name	Foreign, Commonwealth and Development Office
answering dept sort name	Foreign, Commonwealth and Development Office
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, if the Government will take steps to use its Presidency of the G7 to propose support for (a) the WHO COVID-19 Technology Access Pool and (b) increasing Official Development Assistance funding to scale-up vaccine manufacturing capacity in low and middle income countries.
tabling member constituency	Norwich South
tabling member printed	Clive Lewis
uin	149803
answer	answer is ministerial correction date of answer 12/02/2021 answer text <p>The UK will champion rapid equitable access to safe and effective vaccines throughout our G7 Presidency.</p><p>Since the World Health Organisation (WHO) provided initial details on the COVID-19 technology access pool (C-TAP) in October, the UK has led the way in bringing industry and the research community to the table. During our G7 presidency, we will continue this work with stakeholders and the WHO as it establishes the governance structures and refines the operating model for C-TAP.</p><p>The FCDO is working closely with key development partners in vaccines, such as the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccines Alliance, WHO and the United Nations International Children's Emergency Fund (UNICEF), along with development finance institutions and the private sector to catalyse investments for vaccine manufacturing in Africa.</p> answering member constituency Aldridge-Brownhills answering member printed Wendy Morton question first answered 12/02/2021 11:48:39 answering member 4358 label Biography information for Wendy Morton
tabling member	4500 label Biography information for Clive Lewis